New cream for Pre-Cancerous skin spots enters first human safety trial
Disease control
Completed
This was an early safety study of a new topical cream called GZ21T, intended to treat a common sun-damaged skin condition called actinic keratosis. The trial tested single applications of the cream on healthy volunteers to see how much gets absorbed into the body and to check for…
Phase: PHASE1 • Sponsor: Genzada Pharmaceuticals USA, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC